What You Read: My Most Popular Stories

Yesterday, I posted a list of my favorite stories that I wrote in 2011. But which ones were most popular? Here’s a look at my most-read stories. There’s a heavy bias toward the end of the year, because traffic has been going up pretty dramatically. In fact, this list basically ...

Investing in 2012: Resolve to keep it simple

NEW YORK (CNNMoney) — I think too many investors (myself included) try to outsmart the market by constantly fine-tuning their portfolio. Wouldn’t we all be better off just keeping it simple by holding a small handful of index mutual funds or ETFs and just rebalancing that portfolio once a year? ...

2011: The year of annoying fees

Debit card fees weren’t the only annoying new fees customers faced in 2011. NEW YORK (CNNMoney) — Angry Verizon Wireless customers took to chat forums and social networks on Thursday after the company said it would begin to charge customers $2 for making one-time bill payments online or by phone ...

Spain Raises Deficit Forecast

MADRID — Spain’s new conservative government revised upward its forecast for the country’s 2011 budget deficit, saying it would represent 8 percent of its gross domestic product, up from the 6 percent target of the last government. The new administration approved 8.9 billion euros ($11.5 billion) in spending cuts Friday ...

NYT: CEO stock options yield tax boon for firms

The stock market’s rebound from the financial crisis three years ago has created a potential windfall for hundreds of executives who were granted unusually large packages of stock options shortly after the market collapsed. Now, the corporations that gave those generous awards are beginning to benefit, too, in ...

Forecasters see bumpy ride, but better 2012

Buckle your seatbelts. That’s the message analysts have for investors in 2012. Although the S&P 500 is on pace to wrap up this year more or less flat, the stock market gyrated wildly over the last 12 months. The good news is that experts say we’re likely to finish 2012 ...

Wake-Up Call: Mom’s Trip To The Emergency Room

It can be extremely dangerous for aging parents to rely only on memory when it comes to taking medication.  So many aging folks have memory loss issues. A large percentage of those with memory problems go on to develop dementia. The reliance on memory to keep all the pills straight ...

Charities get last-minute boost from donors

NEW YORK (CNNMoney) — Chalk it up to the holiday spirit — or just smart tax planning — but charitable giving is looking up this month. Giving in December is already up 15% from 2010, according to the latest tally by Network for Good, a site that enables donors to ...

Dow’s biggest losers and winners

Click the chart to see how the rest of the Dow components fared this year. NEW YORK (CNNMoney) — When investors look at the change in McDonald’s share price last year, they can think only one thing: “I’m lovin’ it” The fast food giant was the best performer on the ...

Russian Orthodox Church Turns From Kremlin Ally to Critic

MOSCOW — Among the thousands of Russian voices raised against the Kremlin this month after parliamentary elections widely dismissed as fraudulent, perhaps the most surprising was that of Patriarch Kirill I, the leader of the Russian Orthodox Church, who defended popular protests as a “lawful negative reaction” to corruption. Always ...

The biggest new product flops of 2011

GM’s early hopes for the electric Chevy Volt were pretty much dashed by year’s end. Even without a he-said-she-said exchange with the government over battery fires. By Charles B. Stockdale, 24/7 Wall St. A number of incredible new products were launched this year.

Stocks end Thursday trading with healthy gains

Stocks, already posting gains earlier in the day assisted by positive employment and housing news, pushed steadily higher in late-afternoon trading to finish with tidy gains. According to preliminary calculations, noon on Wall Street, the Dow Jones industrial average ended up 135.55 or 1.12 percent, to 12,286.96. The S&P 500 ...

Five Predictions For Biotech And Medicine In 2012

Continuing a proud Forbes tradition, here is what I see happening as we move forward through 2012. 1. We’ll see more super-expensive drugs. Charging $100,000, $200,000, or even $500,000 per patient per year is the most successful strategy in the drug business. One case study: In 2008, the Joint Economic ...

Retailers see 11th-hour surge in holiday sales

NEW YORK (CNNMoney) — It may not be over yet, but retailers are breathing a sigh of relief and celebrating a successful holiday season, thanks to a last-minute surge in sales. Online sales during the final week before Christmas hit $2.8 billion, up 16% from last year, according to ComScore, ...

Court delays SEC case against Citi

The SEC has accused Citigroup of deceiving investors about the quality of mortgage-related securities it sold them. NEW YORK (CNNMoney) — A federal appeals court has delayed proceedings in a mortgage securities fraud case brought by the Securities and Exchange Commission against Citigroup.

Medvedev Promotes Members of Hard-Line Faction in Russia

MOSCOW — President Dmitri A. Medvedev has responded to the street protests in Moscow with proposals for political reform, but his recent personnel appointments seem to tell a different story: top posts went to former officers in the K.G.B. and long-serving loyalists of his political mentor, Vladimir V. Putin. Mr. ...

Bugs may be resistant to genetically modified corn

One of the nation’s most widely planted crops — a genetically engineered corn plant that makes its own insecticide — may be losing its effectiveness because a major pest appears to be developing resistance more quickly than scientists expected. The U.S. food supply is not in any immediate danger ...